XBiotech Inc. Share Price & Technical Analysis
XBIT · $2.43 (-2.02%)
Healthcare / Biotechnology
$2.43
-2.02%
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown,…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
-8% return in May, 11% avg return in past 3 year May month.
6% return in 2026, 3% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 4% | -8% | 5% | 13% | -8% | – | – | – | – | – | – | – | 6% |
| 25 | -12% | 3% | -11% | -9% | -7% | 3% | -3% | 14% | -16% | -12% | 0% | 0% | -49% |
| 24 | 15% | 37% | 29% | -6% | -6% | -30% | 51% | -17% | 20% | -5% | 3% | -47% | 42% |
| 23 | 19% | -24% | 3% | 3% | 46% | 16% | -17% | -4% | -18% | 0% | -7% | 0% | 17% |
| 22 | -3% | -8% | -12% | -10% | -29% | -2% | -9% | -22% | -10% | -3% | -11% | 9% | -110% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$74.24M
P/E ratio
—
52W high
$3.61
52W low
$2.09
Volume
15,209
Beta
0.86
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is XBiotech Inc. share price today?
- XBiotech Inc. (XBIT) last traded around $2.43 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does XBIT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for XBIT. Download the app for real-time alerts.
- How can I analyze XBiotech Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.